{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:58:08Z","timestamp":1792828688821,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1016\/s0959-8049(03)00547-1","type":"journal-article","created":{"date-parts":[[2003,9,12]],"date-time":"2003-09-12T01:10:28Z","timestamp":1063329028000},"page":"1990-2005","source":"Crossref","is-referenced-by-count":477,"title":["Diagnostic and therapeutic management of cancer of an unknown primary"],"prefix":"10.1016","volume":"39","author":[{"given":"N.","family":"Pavlidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Briasoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hainsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.A.","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0959-8049(03)00547-1_BIB1","series-title":"SEER Cancer Statistics Review","author":"Ries","year":"1999"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB2","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0959-8049(02)00135-1","article-title":"Epidemiology of unknown primary tumors","volume":"38","author":"Levi","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0959-8049(01)00378-1","article-title":"Epidemiology of unknown primary tumors; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984\u20131992","volume":"38","author":"van de Wouw","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB4","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/1097-0142(19850215)55:4<857::AID-CNCR2820550425>3.0.CO;2-Z","article-title":"Adenocarcinoma of unknown primary site. The Brooke Army Medical Center experience","volume":"55","author":"Jordan III","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/91.7.599","article-title":"Unknown primary head and neck squamous cell carcinoma","volume":"91","author":"Galifano","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/1097-0142(197010)26:4<816::AID-CNCR2820260413>3.0.CO;2-R","article-title":"Metastatic cancer of unknown primary site","volume":"26","author":"Holmes","year":"1970","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB7","first-page":"139","article-title":"Unknown primary tumors as a unique clinical and biologic entity","volume":"41","author":"Frost","year":"1989","journal-title":"Cancer Bull."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB8","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1200\/JCO.1995.13.8.2094","article-title":"Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin","volume":"13","author":"Abbruzzese","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB9","series-title":"Cancer: Principles and Practice of Oncology","first-page":"2423","article-title":"Cancer of unknown primary site","author":"Greco","year":"1997"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB10","first-page":"2","volume":"37","author":"Silverberg","year":"1987","journal-title":"Cancer Statistics"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/1097-0142(19950101)75:1+<353::AID-CNCR2820751317>3.0.CO;2-P","article-title":"Cancer of unknown primary site","volume":"75","author":"Muir","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB12","series-title":"NSW Central Cancer Registry. Cancer in New South Wales. Incidence and Mortality","author":"Coates","year":"1995"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB13","series-title":"Incidence of Cancer in the Netherlands 1993","author":"Visser","year":"1993"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB14","series-title":"Cancer Incidence in Five Continents, Vol VI. IARC Scientific Publication No. 120","author":"Parkin","year":"1992"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB15","first-page":"13","article-title":"The impact of cancer with unspecified site","volume":"50","author":"Neumann","year":"1988","journal-title":"Off Gesundheitswes"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB16","first-page":"1","article-title":"Cancer metastases from an unestablished primary tumor (clinical aspects, diagnosis, treatment)","volume":"4","author":"Komov","year":"1991","journal-title":"Sov. Med. Rev. F. Oncology"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB17","series-title":"Cancer Incidence in Five Continents, vol VII. IARC No 143","author":"Parkin","year":"1991"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB18","first-page":"53","article-title":"Metastatic and histologic presentation in unknown primary cancer","volume":"4","author":"Nystrom","year":"1977","journal-title":"Semin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1634\/theoncologist.2-3-142","article-title":"Cancer of unknown primary origin","volume":"2","author":"Briasoulis","year":"1997","journal-title":"Oncologist"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB20","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1200\/JCO.1994.12.6.1272","article-title":"Unknown primary carcinoma","volume":"12","author":"Abbruzzese","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB21","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.1998.16.6.2105","article-title":"Unknown primary tumors metastatic to liver","volume":"16","author":"Ayoub","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB22","first-page":"204","article-title":"Extragonadal germ cell malignancy","volume":"20","author":"Richardson","year":"1979","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB23","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0140-6736(79)91949-4","article-title":"Undifferentiated carcinoma in young men","volume":"i","author":"Fox","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/0003-4819-94-2-181","article-title":"The unrecognized extragonadal germ cell syndrome","volume":"94","author":"Richardson","year":"1981","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.7326\/0003-4819-104-4-547","article-title":"Advanced poorly differentiated carcinoma of unknown primary site","volume":"142","author":"Greco","year":"1986","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB26","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.1987.5.8.1275","article-title":"Poorly differentiated carcinoma of unknown primary site","volume":"5","author":"Hainsworth","year":"1987","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-109-5-364","article-title":"Poorly differentiated neuroendocrine carcinoma of unknown primary site","volume":"109","author":"Hainsworth","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/oxfordjournals.annonc.a057688","article-title":"Carcinoma of unknown primary","volume":"1","author":"Van der Gaast","year":"1990","journal-title":"Ann. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB29","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/1097-0142(19901001)66:7<1461::AID-CNCR2820660704>3.0.CO;2-Z","article-title":"Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin","volume":"66","author":"Ellerbroek","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0360-3016(99)00542-8","article-title":"Occult breast carcinoma presenting as axillary metastases","volume":"47","author":"Foroudi","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10434-001-0425-6","article-title":"Feasibility of breast presentation in the treatment of occult primary carcinoma presenting with axillary metastases","volume":"8","author":"Vlastos","year":"2001","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB32","first-page":"431","article-title":"Axillary metastases from occult breast carcinoma","volume":"61","author":"Jackson","year":"1995","journal-title":"Am. Surg."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0167-8140(00)00172-9","article-title":"Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology","volume":"55","author":"Grau","year":"2000","journal-title":"Radiother. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0360-3016(01)01462-6","article-title":"Cervical lymph node metastases from occult squamous cell carcinoma","volume":"50","author":"Nieder","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB35","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/1097-0142(19870201)59:3<572::AID-CNCR2820590336>3.0.CO;2-3","article-title":"Metastatic inguinal nodes from an unknown primary neoplasm. A review of 56 cases","volume":"19","author":"Guarischi","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB36","series-title":"Cancer Treatment","first-page":"798","article-title":"Metastases on unknown origin","author":"Casciato","year":"1990"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB37","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/1097-0142(19860915)58:6<1371::AID-CNCR2820580632>3.0.CO;2-L","article-title":"Peritoneal papillary serous carcinoma with long-term survival","volume":"58","author":"Chen","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/1097-0142(19890701)64:1<110::AID-CNCR2820640120>3.0.CO;2-5","article-title":"Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases","volume":"64","author":"Dalrymple","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB39","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/1097-0142(19900915)66:6<1091::AID-CNCR2820660602>3.0.CO;2-F","article-title":"Papillary serous carcinoma of the peritoneum","volume":"66","author":"Ransom","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB40","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V","article-title":"Peritoneal carcinomatosis in nongynecologic malignancy","volume":"63","author":"Chu","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB41","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1001\/jama.1985.03350480082024","article-title":"Atypical metastasis from prostate cancer","volume":"253","author":"Tell","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB42","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/1097-0142(19880815)62:4<711::AID-CNCR2820620411>3.0.CO;2-6","article-title":"Disseminated prostatic carcinoma simulating primary lung cancer","volume":"62","author":"Gentile","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB43","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/1097-0142(19850815)56:4<880::AID-CNCR2820560430>3.0.CO;2-I","article-title":"Sites of primary malignancies in patients presenting with cerebral metastases. A review of 120 cases","volume":"56","author":"Le Chevalier","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB44","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2181::AID-CNCR17>3.0.CO;2-J","article-title":"Brain metastases as the only manifestation of an undetected primary tumor","volume":"83","author":"Nguyen","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB45","first-page":"941","article-title":"Management of brain metastases","volume":"13","author":"Wen","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I","article-title":"Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin","volume":"68","author":"Moertel","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB47","first-page":"341","article-title":"Malignant melanoma of unknown primary origin","volume":"117","author":"Das Gupta","year":"1963","journal-title":"Surg. Gynecol. Obst."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB48","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/1097-0142(19820315)49:6<1106::AID-CNCR2820490607>3.0.CO;2-0","article-title":"Metastatic melanoma of unknown primary","volume":"49","author":"Chang","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<60::AID-CNCR8>3.0.CO;2-J","article-title":"Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma","volume":"80","author":"Schlagenhauff","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB50","first-page":"1619","article-title":"p53 gene mutation spectrum in human unknown primary tumors","volume":"13","author":"Bar-Eli","year":"1993","journal-title":"Anticancer Res."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB51","first-page":"1907","article-title":"Bcl2 and p53 protein expression in metastatic carcinoma of unknown primary origin","volume":"18","author":"Briasoulis","year":"1998","journal-title":"Anticancer Res."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB52","first-page":"2563","article-title":"Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary origin","volume":"15","author":"Pavlidis","year":"1995","journal-title":"Anticancer Res."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB53","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1200\/JCO.2000.18.3.632","article-title":"Overexpression of Her-2 in patients with poorly differentiated carcinoma or poorly differentiated adenocarcinoma of unknown primary site","volume":"18","author":"Hainsworth","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB54","unstructured":"Karavasilis V, Tsanou E, Malamou-Mitsi V, et al. Microvessel density and vascular endothelial growth factor in cancer of unknown primary. An immunohistochemical study. Proc ESMO, 2002, 51p."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB55","first-page":"206","article-title":"Pathological evaluation of neoplasm with unknown primary tumor site","volume":"20","author":"Mackey","year":"1993","journal-title":"Semin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<171::AID-CNCR24>3.0.CO;2-V","article-title":"Adenocarcinoma metastatic to the liver","volume":"85","author":"Tot","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB57","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0959-8049(02)00008-4","article-title":"Cytokeratins 20 and 7 as biomarkers","volume":"38","author":"Tot","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB58","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1200\/JCO.1995.13.1.274","article-title":"Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site","volume":"13","author":"Motzer","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB59","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(82)91557-4","article-title":"Specific chromosome change, i(12p) in testicular tumors","author":"Atkin","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB60","first-page":"229","article-title":"Genetic analysis in the diagnosis of neoplasm of unknown primary tumor site","volume":"20","author":"Ilson","year":"1993","journal-title":"Semin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB61","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/archinte.1988.00380090101024","article-title":"Early metastatic cancer of unknown origin at presentation. A clinical study of 302 consecutive autopsied patients","volume":"148","author":"Le Chevalier","year":"1988","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB62","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.1979.03290300023020","article-title":"Identifying the primary site in metastatic cancer of unknown origin. Inadequacy of roentgenographic procedures","volume":"241","author":"Nystrom","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB63","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1136\/bmj.1.6177.1530","article-title":"Unknown primary adenocarcinoma","volume":"1","author":"Stewart","year":"1979","journal-title":"Br. Med. J."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB64","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jama.1982.03330030046024","article-title":"Computed tomography in search of cancer of unknown origin","volume":"248","author":"Karsell","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB65","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1148\/radiology.143.1.7063718","article-title":"Computed tomography in the evaluation of metastatic adenocarcinoma from an unknown primary site. A retrospective study","volume":"143","author":"McMillan","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB66","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archsurg.1990.01410140088014","article-title":"Occult breast cancer presenting with axillary metastases. Updated management","volume":"125","author":"Baron","year":"1990","journal-title":"Arch. Surg."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB67","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1148\/radiology.212.2.r99au40543","article-title":"Breast MR Imaging in patients with axillary node metastases and unknown primary malignancy","volume":"212","author":"Orel","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB68","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0959-8049(99)00077-5","article-title":"18F-FDG whole body position emission tomography (PET) in patients with unknown primary tumors (UPT)","volume":"35","author":"Lassen","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB69","first-page":"816","article-title":"FDG PET detection of unknown primary tumors","volume":"41","author":"Bohuslavizki","year":"2000","journal-title":"J. Nucl. Med."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB70","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1067\/mhn.2000.104807","article-title":"2[F]-Fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation","volume":"123","author":"Jungehulsing","year":"2000","journal-title":"Otolaryngol Head Neck Surg."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB71","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1095-0397(00)00053-4","article-title":"Metastases from unknown primary tumor. PET-FDG as initial diagnostic procedure?","volume":"3","author":"Lonneux","year":"2000","journal-title":"Clin Positron Imag."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB72","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1023\/A:1013107732572","article-title":"Localised disease in cancer of unknown primary (CUP)","volume":"12","author":"Rades","year":"2001","journal-title":"Ann. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB73","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1023\/A:1008265113591","article-title":"Detection of primary breast cancer presenting as metastatic carcinoma of unknown primary origin by 111In-pentetreotide scan","volume":"9","author":"Lenzi","year":"1998","journal-title":"Ann. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB74","first-page":"MT25","article-title":"Tumor markers in metastatic disease from cancer of unknown primary origin","volume":"8","author":"Milovic","year":"2002","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB75","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/mpo.2950220303","article-title":"Evaluation of six tumor markers in patients with carcinoma of unknown primary","volume":"22","author":"Pavlidis","year":"1994","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB76","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/1097-0142(19871101)60:9<2233::AID-CNCR2820600922>3.0.CO;2-Y","article-title":"High serum thyroglobulin levels. Diagnostic indicators in patients with metastases from unknown primary sites","volume":"60","author":"Panza","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB77","first-page":"152","article-title":"Serum tumor markers as diagnostic aids in patients with unknown primary tumors","volume":"41","author":"Shahangian","year":"1989","journal-title":"Cancer Bull."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB78","first-page":"39","article-title":"The role of CA 125 in patients with unknown primary tumors","volume":"10","author":"Abbruzzese","year":"1991","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB79","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-9610(67)90309-1","article-title":"Metastatic cancer without a detectable primary site","volume":"113","author":"Smith","year":"1967","journal-title":"Am. J. Surg."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB80","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0009-9260(70)80123-4","article-title":"Secondary carcinoma in cervical lymph nodes with an occult primary tumor. A review of 61 patients including their response to radiotherapy","volume":"21","author":"Probert","year":"1970","journal-title":"Clin. Radiol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB81","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2214\/ajr.111.1.95","article-title":"Cervical lymph node metastases from carcinoma of undetermined origin","volume":"111","author":"Pico","year":"1971","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB82","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000224675","article-title":"Chemotherapy in the management of metastatic cancer of unknown primary site","volume":"26","author":"Lleander","year":"1972","journal-title":"Oncology"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB83","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/1097-0142(197212)30:6<1469::AID-CNCR2820300609>3.0.CO;2-T","article-title":"Treatment of the patient with adenocarcinoma of unknown origin","volume":"30","author":"Moertel","year":"1972","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB84","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00000658-197711000-00014","article-title":"Metastatic carcinomas from occult primary tumours. A study of 254 patients","volume":"186","author":"Didolkar","year":"1977","journal-title":"Ann. Surg."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB85","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mpo.2950060404","article-title":"Adenocarcinoma of unknown primary site","volume":"6","author":"Snyder","year":"1979","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB86","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1148\/radiology.134.2.7352215","article-title":"Diagnostic persistence in working-up metastatic cancer with an unknown primary site","volume":"134","author":"Steckel","year":"1980","journal-title":"Radiology"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB87","first-page":"77","article-title":"Management of patients with metastatic adenocarcinoma of unknown origin","volume":"67","author":"Shildt","year":"1983","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB88","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1200\/JCO.1986.4.11.1652","article-title":"Prognostic factors in metastatic carcinoma of unknown primary","volume":"4","author":"Pasterz","year":"1986","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB89","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/oxfordjournals.annonc.a058290","article-title":"Subsets of tumors responsive to cisplatin or carcboplatin combination in patients with carcinoma of unknown primary site","volume":"3","author":"Pavlidis","year":"1992","journal-title":"Ann. Oncol."},{"issue":"Suppl. 12","key":"10.1016\/S0959-8049(03)00547-1_BIB90","first-page":"77","article-title":"Poorly differentiated carcinoma or adenocarcinoma of unknown primary site","volume":"21","author":"Greco","year":"1994","journal-title":"Semin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB91","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1159\/000011890","article-title":"Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site","volume":"55","author":"Briasoulis","year":"1998","journal-title":"Oncol."},{"issue":"Suppl. 12","key":"10.1016\/S0959-8049(03)00547-1_BIB92","first-page":"129","article-title":"The evolving role of paclitaxel for patients with carcinoma of unknown primary site","volume":"26","author":"Greco","year":"1999","journal-title":"Semin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB93","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/A:1008369812295","article-title":"Carcinoma of unknown primary site","volume":"11","author":"Greco","year":"2000","journal-title":"Ann. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB94","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/1097-0142(20001215)89:12<2655::AID-CNCR19>3.0.CO;2-9","article-title":"Carcinoma of unknown primary site. Long term follow-up after treatment with paclitaxel, carboplatin and etoposide","volume":"89","author":"Greco","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB95","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1200\/JCO.2000.18.17.3101","article-title":"Carboplatin plus paclitaxel in unknown primary carcinoma","volume":"18","author":"Briasoulis","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB96","first-page":"203","article-title":"Taxane-based chemotherapy for patients with carcinoma of unknown primary site","volume":"7","author":"Greco","year":"2001","journal-title":"Cancer J."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB97","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/00000421-200012000-00018","article-title":"Multicentric phase II study of cisplatin and etoposide in patients with metastatic carcinoma of unknown primary","volume":"23","author":"Voog","year":"2000","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB98","first-page":"1455","article-title":"5-fluorouracil and leucovorin as second line chemotherapy in carcinomas of unknown primary site","volume":"21","author":"Culine","year":"2001","journal-title":"Anticancer Res."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB99","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1081\/CNV-100103127","article-title":"Gemcitabine in the second- line therapy of patients with carcinoma of unknown primary site","volume":"19","author":"Hainsworth","year":"2001","journal-title":"Cancer Invest."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB100","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1023\/A:1026478009050","article-title":"Chemotherapy in carcinomas of unknown primary site","volume":"10","author":"Culine","year":"1999","journal-title":"Ann. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB101","first-page":"926","article-title":"Combination chemotherapy with 5-fluorouracil, adriamycin, cyclophosphamide, and cis-platinum in the treatment of adenocarcinoma of unknown primary and undifferentiated carcinomas","author":"Jadeja","year":"1983","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB102","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/0277-5379(87)90443-3","article-title":"Metastatic adenocarcinoma of unknown primary site","volume":"23","author":"Milliken","year":"1987","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB103","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0277-5379(89)90133-8","article-title":"Fluorouracil, doxorubicin, cisplatin and altretanine in the treatment of metastatic carcinoma of unknown primary","volume":"25","author":"Becouarn","year":"1989","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB104","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/oxfordjournals.annonc.a058007","article-title":"Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic carcinoma of unknown primary origin","volume":"2","author":"Raber","year":"1991","journal-title":"Ann. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB105","first-page":"301","article-title":"Cisplatin, 5-fluorouracil and follinic acid for the treatment of carcinoma of unknown primary","volume":"10","author":"Lenzi","year":"1991","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB106","first-page":"123","article-title":"High dose intensity of cisplatin and etoposide in adenocarcinoma of unknown primary","volume":"11","author":"Gill","year":"1991","journal-title":"Anticancer Res."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB107","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0277-5379(91)90182-D","article-title":"Phase II trial of cisplatin in adenocarcinoma of unknown primary site","volume":"27","author":"Wagener","year":"1991","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB108","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000011845","article-title":"Mitomycin, epirubicin and cisplatin versus mitomycin-C alone as therapy for carcinoma of unknown primary origin","volume":"55","author":"Falkson","year":"1998","journal-title":"Oncology"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB109","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1038\/bjc.1998.395","article-title":"A multicenter phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site (CUPS)","volume":"77","author":"Warner","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB110","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1023\/A:1008309204979","article-title":"Management of adenocarcinoma of unknown primary with a 5-fluorouracil-cisplatin chemotherapy regimen (CFT arm)","volume":"10","author":"Lofts","year":"1999","journal-title":"Ann. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB111","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00000421-200108000-00012","article-title":"Combination of cisplatin-doxorubicin-cyclophosphamide in adenocarcinoma of unknown primary site","volume":"24","author":"Guardiola","year":"2001","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB112","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1023\/A:1011129429499","article-title":"Carcinoma of an unknown primary site","volume":"12","author":"Saghatchian","year":"2001","journal-title":"Ann. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB113","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/sj.bjc.6600258","article-title":"A phase II study of mitomycin C, cisplatin and continuous infusion 5-fluorouracil (UCF) in the treatment of patients with carcinoma of unknown primary site","volume":"86","author":"Macdonald","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB114","first-page":"609","article-title":"Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary","volume":"153a","author":"Lortholary","year":"2002","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB115","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/1097-0142(20010201)91:3<592::AID-CNCR1039>3.0.CO;2-5","article-title":"A randomized phase II trial in patients with carcinoma of an unknown primary site","volume":"91","author":"Dowell","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB116","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1200\/JCO.20.6.1651","article-title":"Gemcitabine, carboplatin and paclitaxel for patients with carcinoma of unknown primary site","volume":"20","author":"Greco","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB117","first-page":"88","article-title":"Paclitaxel, cisplatin and gemcitabine in the treatment of unknown primary tumours, a phase II study","volume":"25","author":"Gothelf","year":"2002","journal-title":"Proc ESMO"},{"key":"10.1016\/S0959-8049(03)00547-1_BIB118","first-page":"2298","article-title":"A multicenter phase II study of docetaxel and cisplatin in the treatment of cancer of unknown primary site","volume":"137b","author":"Bouleuc","year":"2001","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/S0959-8049(03)00547-1_BIB119","first-page":"2151","article-title":"Phase II study of single agent docetaxel in carcinoma of unknown primary site","volume":"100b","author":"Darby","year":"2001","journal-title":"Proc. Am. Soc. Clin. Oncol."}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804903005471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804903005471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T12:15:30Z","timestamp":1585138530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804903005471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":119,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["S0959804903005471"],"URL":"https:\/\/doi.org\/10.1016\/s0959-8049(03)00547-1","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}